Franco Odicino

ORCID: 0000-0001-8870-4739 · 13 papers in corpus
diagnostic-accuracy 2026
Human Reproduction ·doi:10.1093/humrep/deaf221

STUDY QUESTION: Can a serum miRNA signature serve as a potential diagnostic biomarker for endometriosis (END)? SUMMARY ANSWER: A miRNA-based diagnostic model demonstrated an accuracy of 65.8% in distinguishing END patients from control sub…

meta-analysis 2025
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.70164

BACKGROUND: OHVIRA syndrome, a urogenital malformation, lacks standardized management. Narrative reviews exist, but there is no a comprehensive meta-analysis. OBJECTIVES: The aim of this first systematic review and meta-analysis is to eval…

review 2025
Journal of clinical medicine ·doi:10.3390/jcm14217815

Background: Desmoid tumors (DTs) are rare, locally aggressive soft-tissue neoplasms that often affect women of reproductive age. Pregnancy and prior abdominal surgery or trauma have been associated with tumor development and growth, while i…

diagnostic-accuracy 2025
·doi:10.23736/s0393-0564.25.00034-2

INTRODUCTION: Endometriosis (END) is a debilitating gynecological disorder. Clinical examination, imaging, and laparoscopy can provide a definitive diagnosis of END. The discovery of non-invasive biomarkers is necessary to overcome the disa…

other 2024
Biomedicines ·doi:10.3390/biomedicines12102393

BACKGROUND/OBJECTIVES: Endometriosis (END) is a painful gynecological condition. Clinical examination, imaging, and laparoscopy can provide a definitive diagnosis of END. Nonetheless, non-invasive biomarkers could help enhance and streamlin…

observational 2024
Women's health (London, England) ·doi:10.1177/17455057241252573

BACKGROUND: Almost 10% of women in reproductive age are diagnosed with ovarian endometriomas and can experience symptoms and infertility disorders. Ovarian endometriomas can be treated with medical or surgical therapy. OBJECTIVE: To assess…

review 2024
Frontiers in medicine ·doi:10.3389/fmed.2024.1387036

Endometriosis is a chronic debilitating disease that affects nearly 10% of women of the reproductive age. Although the treatment modalities of endometriosis are numerous, surgical excision of the endometriotic implants and nodules remains t…

review 2023
Journal of clinical medicine ·doi:10.3390/jcm12144846

BACKGROUND: Mesonephric adenocarcinoma (MA) of the vagina is a rare tumor that arises from mesonephric remnants (Wolffian) in the female genital tract. It is a neoplasm with no significant evidence about its diagnosis, treatment, follow-up …

meta-analysis 2021
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.14635

AIM: The scar of cesarean section (CS) is the most common site of abdominal wall endometriosis (AWE), whose tumor degeneration has been reported in an increasing number of cases; the most frequent histological type is clear cell carcinoma (…

review 2020
Journal of clinical medicine ·doi:10.3390/jcm9082552

BACKGROUND: Intestinal metaplasia/differentiation in primary endometrial carcinomas is an uncommon phenomenon, with only few cases described. MATERIAL AND METHODS: We performed a systematic review of endometrial carcinomas with intestinal …

case-report 2018
·doi:10.1177/2284026518808159

Introduction: Parametrial endometriosis could often involve the ureter and periureteral tissue causing hydronephrosis and distortion of the normal ureteral course and position. The treatment in the case of hydronephrosis could be ureterolys…

other 2017
Journal of experimental & clinical cancer research : CR ·doi:10.1186/s13046-017-0536-y

BACKGROUND: Epithelial ovarian cancer (EOC) is a spectrum of different diseases, which makes their treatment a challenge. Forkhead box M1 (FOXM1) is an oncogene aberrantly expressed in many solid cancers including serous EOC, but its role i…

diagnostic-accuracy 2011
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology ·doi:10.1158/1055-9965.EPI-11-0635

BACKGROUND: The aim of this work was to analyze the diagnostic and prognostic value of serum human epididymis protein 4 (HE4) and Risk for Ovarian Malignancy Algorithm (ROMA) in epithelial ovarian cancer (EOC). METHODS: Preoperative serum …